Spontaneous regression of incidentally diagnosed bronchial squamous cell lung carcinoma after severe bronchitis: A case report.

Spontaneous neoplasm regression carcinoma inflammation lung neoplasms squamous cell

Journal

SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686

Informations de publication

Date de publication:
2021
Historique:
received: 03 12 2020
accepted: 23 03 2021
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 27 5 2021
Statut: epublish

Résumé

Spontaneous regression of lung cancer is exceptionally rare. But there have been several intriguing cases reported in early and even advanced stages of lung cancer. Although the exact mechanism remains to be elucidated, the inflammation and immunologic response have been suggested as one of the means of spontaneous regression. Chronic inflammation is generally known to induce and aggravate tumorigenesis, but the relationship between cancer and inflammation highly depends on the contexts. Here, we present a case of a 60-year-old male ex-smoker who complained of recurrent hemoptysis, cough, and purulent sputum. The initial chest CT scan revealed diffuse bronchial thickening and an endobronchial mass-like lesion in the left lingular segment. The bronchoscopic and pathological findings also suggested a diagnosis of squamous cell carcinoma with severe mucosal inflammation. He was treated with antibiotics for the bronchitis during the first 1 week and his symptoms markedly improved. After 3 weeks, he underwent a follow-up examination. Chest computed tomography and bronchoscopy revealed the significant improvement of the bronchial narrowing and mucosal edema. Biopsy was performed several times around the lesion where the tissue was initially taken. However, the pathological results showed only chronic inflammation of bronchi, not cancer cells. Fortunately, there was no recurrence of lung cancer in follow-up chest computed tomography or bronchoscopy for almost 5 years. In this case, the incidentally diagnosed bronchial squamous cell carcinoma disappeared after severe inflammatory reaction of the bronchial wall. The clinician should remind the risk of early lung cancer accompanied with bronchitis in high-risk patients of lung cancer and also be aware that although it is very rare, the lesions could spontaneously regress.

Identifiants

pubmed: 34035913
doi: 10.1177/2050313X211010639
pii: 10.1177_2050313X211010639
pmc: PMC8132097
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2050313X211010639

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Lung Cancer. 2019 Sep;135:188-195
pubmed: 31446994
Mucosal Immunol. 2015 Sep;8(5):959-68
pubmed: 26174765
Clin Case Rep. 2018 Apr 06;6(6):995-998
pubmed: 29881550
Thorac Cancer. 2015 Nov;6(6):805-7
pubmed: 26557923
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
J Inflamm Res. 2009;2:1-11
pubmed: 22096348
Prog Clin Cancer. 1967;3:79-95
pubmed: 4867093
Adv Exp Med Biol. 2014;816:1-23
pubmed: 24818717
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
IUBMB Life. 2019 Feb;71(2):152-165
pubmed: 30466159
Int J Environ Res Public Health. 2019 Dec 30;17(1):
pubmed: 31905913
J Thorac Oncol. 2007 Feb;2(2):168-70
pubmed: 17410036
Lung Cancer. 2004 Aug;45(2):263-6
pubmed: 15246199
Ann Thorac Cardiovasc Surg. 2011;17(6):577-9
pubmed: 21881362
Cancer Metastasis Rev. 2015 Jun;34(2):319-31
pubmed: 26059063
J Surg Oncol. 1981;17(3):201-9
pubmed: 6166811
Thorac Cancer. 2018 Dec;9(12):1778-1781
pubmed: 30311443
Sci Transl Med. 2014 Dec 3;6(265):265sr6
pubmed: 25473038
Cancer Prev Res (Phila). 2016 Jan;9(1):96-104
pubmed: 26542061
Ther Adv Med Oncol. 2013 Jul;5(4):235-48
pubmed: 23858332
Clin Lung Cancer. 2018 Mar;19(2):120-129
pubmed: 29153898

Auteurs

Yoonjoo Kim (Y)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.

Geon Yoo (G)

Clinical Research Division, National Institute of Food and Drug Safety Evaluation, Cheongju-si, Republic of Korea.

Da-Hye Lee (DH)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.

Choong-Sik Lee (CS)

Department of Pathology, Konyang University Hospital, Daejeon, Republic of Korea.

Chaeuk Chung (C)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.

Classifications MeSH